NetCurl - Slashdot User

Comment Re:Spin (Score 1) 420

by NetCurl on Sunday December 27, 2009 @09:14PM (#30567260) Attached to: Consumerist Says AT&T Site Won't Sell iPhone In NYC, Citing Network

What the heck are you talking about? <-- Note the pretty pie chart.

You're ridiculous. The chart you started this thread with is GLOBAL market share. The blurb clearly delineates US-based market share preference for the iPhone, and given AT&T is a US-based carrier, the share of Symbian OS globally is a silly thing to compare against. Note this chunk:

"Considering Apple's gadget is currently the most popular handset in the U.S., its exclusive carrier's inability/unwillingness to support the device in the country's largest market is pretty huge news. If this proves true, I'd expect curtains for AT&T's exclusivity deal when it comes up for renewal.""

OK, here's the US-based share: http://www.boygeniusreport.com/2009/10/28/rim-and-apple-top-u-s-smartphone-market-share/

Given this, RIM is actually the favorite. I did no digging into the source of the data, but it appeared in numerous places and seemed to be well reviewed. It does not include Droid as it was published in late October 2009.

It also proves wrong the 1-2% commenter. iPhone is quite popular in US, but RIM still holds the edge.

Licensed C64 Emulator Rejected From App Store 277

Posted by Soulskill on Sunday June 21, 2009 @12:54PM from the insufficient-quantities-of-hip dept.

Miasik.Net writes "A fully licensed Commodore 64 iPhone emulator has been rejected from the App Store. The excuse Apple used is a clause in the SDK agreement which doesn't allow for applications that run executable code. It seems Sega is exempt from that clause, because some of its games on the iPhone are emulators running original ROM code."

Mayo Clinic Reports Dramatic Outcomes In Prostate Cancer Treatment 122

Posted by Soulskill on Sunday June 21, 2009 @11:24AM from the turns-out-the-tumor-was-his-sled dept.

Zorglub writes "Two prostate cancer patients who had been told their condition was inoperable are now cancer-free as the result of an experimental therapy, the Mayo Clinic in Rochester announced Friday. 'Cancer has a propensity for turning off T cells. Dr. Allison hypothesized that if you block the off-switch, T cells will stay turned on and create a prolonged immune response. Dr. Kwon, then at NIH, demonstrated that CTLA-4 blockage could be used to treat aggressive forms of prostate cancer in mice. There was one limitation to that concept — the worry that by simply leaving all the T cells on there may not be enough response aimed at the tumor. Dr. Kwon called Dr. Allison and designed the trial together. The idea: use androgen ablation or hormone therapy to ignite an immune approach — a pilot light — and then, after a short interval of hormone therapy, introduce an anti-CTLA-4 antibody that acts like gasoline to this pilot light and overwhelms the cancer cells.' After the treatment, the patients' tumors shrunk to such a degree that they could be successfully removed."

Slashdot Top Deals